Adis Journals
Browse
Summary slide.png (88.29 kB)
Download file

Cost-Utility Analysis of Nivolumab in the Adjuvant Treatment of Melanoma in France

Download (88.29 kB)
media
posted on 2020-09-11, 15:40 authored by Bruno Bregman, Siguroli Teitsson, Isabella Orsini, François-Emery Cotté, Adenike Amadi, Andriy Moshyk, Stéphane Roze, Anne-Françoise Gaudin

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Usage metrics

    Dermatology and TherapyDermatology and Therapy

    Categories

    Keywords

    Adjuvant melanomaCost-effectivenessFranceNivolumab

    Licence

    CC BY-NC 4.0

    Exports